loading

Lexicon Pharmaceuticals Inc Azioni (LXRX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
2,187%
28.87
1.262 26.55 1.75 1.647
Cost Of Revenue
10.00%
0.033
0.03 0.348 0.071 0.166
Gross Profit
2,240%
28.83
1.232 26.21 1.679 1.481
Operating Expenses
6.74%
25.10
26.91 58.94 65.37 56.84
Benefits Costs and Expenses
6.72%
25.13
26.94 59.29 65.44 57.00
Costs And Expenses
6.72%
25.13
26.94 59.29 65.44 57.00
Operating Income/Loss
114.55%
3.736
-25.68 -32.74 -63.69 -55.35
Income/Loss From Continuing Operations Before Tax
114.77%
3.736
-25.30 -32.74 -63.69 -53.43
Income/Loss From Continuing Operations After Tax
112.86%
3.252
-25.30 -33.77 -64.81 -53.43
Net Income/Loss
112.86%
3.252
-25.30 -33.77 -64.81 -53.43
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.34%
363.29
362.07 13.92 361.49 310.84
Diluted Average Shares
0.41%
363.57
362.07 13.92 361.49 310.84
Basic Earnings Per Share
114.29%
0.01
-0.07 -0.09 -0.18 -0.17
Diluted Earnings Per Share
114.29%
0.01
-0.07 -0.09 -0.18 -0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):